ORAGENICS, INC. Prepaid Expense, Current
ORAGENICS, INC. (OGEN) had Prepaid Expense, Current of $208.13 thousand as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2025-05-09
- 2025-03-31: Prepaid Expense, Current $208.13K.
- 2024-12-31: Prepaid Expense, Current $177.44K.
- 2024-09-30: Prepaid Expense, Current $386.04K.
- 2024-06-30: Prepaid Expense, Current $248.31K.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2025-03-31 | $208.13K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $177.44K 10-Q · filed 2025-05-09 | |
| 2024-09-30 | $386.04K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $248.31K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $237.24K 10-Q · filed 2024-05-15 | |
| 2023-06-30 | $1.60M 10-Q · filed 2023-08-11 | |
| 2022-12-31 | $2.47M 10-K · filed 2024-03-29 | $2.84M 10-K · filed 2023-04-17 |
| 2022-09-30 | $2.55M 10-Q/A · filed 2023-04-14 | |
| 2022-06-30 | $1.97M 10-Q/A · filed 2023-04-14 | |
| 2022-03-31 | $1.70M 10-Q/A · filed 2023-04-14 | |
| 2021-12-31 | $416.76K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |